Effectiveness of PVP-I
| % corneas not contaminated (n/ ntotal) | |||
|---|---|---|---|
| Exposure time (minutes) | |||
| 2 | 10 | ||
| PVP-I 5 mg/ml | 69 (18/26) | 63 (17/27) | |
| PVP-I 20 mg/ml | 68 (15/22) | 83 (20/24) | |
| PVP-I 50 mg/ml | 65 (15/23) | 66 (19/29) | |
| PVP-I 100 mg/ml | 67 (16/24) | 80 (20/25) | |
Effectiveness of PVP-I
| % corneas not contaminated (n/ ntotal) | |||
|---|---|---|---|
| Exposure time (minutes) | |||
| 2 | 10 | ||
| PVP-I 5 mg/ml | 69 (18/26) | 63 (17/27) | |
| PVP-I 20 mg/ml | 68 (15/22) | 83 (20/24) | |
| PVP-I 50 mg/ml | 65 (15/23) | 66 (19/29) | |
| PVP-I 100 mg/ml | 67 (16/24) | 80 (20/25) | |
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of
BJO.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.